Transcript Highlights:

• It's to remember and recognize his work, his influence on civil engagement, youth leadership, and constitutional
• But by contrast, this bill asks us to honor a partisan national influencer with no meaningful ties to
• But by contrast, this bill asked us to honor a partisan national influencer with no meaningful ties to

Summary: The Committee on Governmental Oversight and Accountability took up three bills. First, it heard Senator Gates’s employee protection bill, which would create whistleblower-style protections for people who file ethics complaints based on personal knowledge, allowing the Ethics Commission to investigate retaliation and, if probable cause is found, letting the complainant seek administrative or civil relief. The Commission on Ethics supported the measure, saying it had long recommended such protections and that implementation costs would be low. The committee adopted the delete-all amendment and then reported the committee substitute for Senate Bill 92 favorably. Next, the committee considered Senate Bill 60 by Senator McLean, which reclassifies certain district assistant regional counsel supervisor positions in the Florida Retirement System to the senior management class, aligning them more closely with comparable attorney positions in public defender and state attorney offices. A late-file technical amendment aligning class codes with Florida statutes was adopted, and the bill was reported favorably. A representative from the regional council spoke in support. Finally, the committee heard Senate Bill 194 by Senator Martin, which would designate October 14 as Charlie Kirk Day of Remembrance. The sponsor argued the day would honor Kirk’s advocacy for free speech, debate, and civic engagement, and said it would not create a state holiday or require closures. The bill drew strong opposition from Senator Polsky and Senator Bracy Davis, who cited Kirk’s public comments on race, women, gun violence, and systemic discrimination and argued he was not a unifying figure worthy of state honor. Julie Keefe also spoke against the bill, while representatives from the Venezuelan American Republican Club and the Christian Family Coalition spoke in support. Despite the debate, the committee voted to report Senate Bill 194 favorably.

Transcript Highlights:

• It's to remember and recognize his work, his influence on civic engagement, youth leadership, and constitutional
• But by contrast, this bill asks us to honor a partisan national influencer with no meaningful ties to
• But by contrast, this bill asks us to honor a partisan national influencer with no meaningful ties to

Committee: Senate Governmental Oversight and Accountability

Summary: The Committee on Governmental Oversight and Accountability heard three bills and reported all three favorably. First, the committee took up Senator Gates’ employee protection bill, which was amended with a delete-all to create whistleblower protections for people who file ethics complaints based on personal knowledge. Gates and the Florida Commission on Ethics said the measure would reduce retaliation against insiders who report misconduct, while the commission said it supported the proposal and expected low implementation costs. The committee adopted the amendment and then passed the bill as amended. The committee next considered Senator McClain’s bill to reclassify certain district assistant regional counsel supervisor positions in the Florida Retirement System to the senior management class. Supporters said the change would align those positions with comparable attorneys in public defender and state attorney offices and help with recruitment and retention. A late-file technical amendment aligning class codes with statute was adopted, and the committee then reported the bill favorably. The final bill, Senator Martin’s SB 194, would designate October 14 each year as Charlie Kirk Day of Remembrance in Florida. Martin argued the day would honor Kirk’s advocacy for free speech, civic engagement, and debate, and said it would not create a state holiday or require closures. The bill drew strong opposition from Senator Polsky and Senator Bracy Davis, who cited Kirk’s public statements on race, women, guns, and systemic discrimination and argued he was divisive and unworthy of a state honor. Supporters, including representatives from the Venezuelan American Republican Club and the Christian Family Coalition, backed the measure. After debate, the committee voted to report the bill favorably. The meeting then adjourned.

Transcript Highlights:

• But to that same logic, customers of FPL don't necessarily have any influence over the next era CEO,
• And so— Don't necessarily have any influence over the NextEra CEO, who is not based in Florida.
• Because, I mean, candidly, customers of IOUs don't have a lot of influence at all.

Summary: The Economic Infrastructure Subcommittee met with a quorum present and considered five bills. The first, PCS for HB 987, was an honorary transportation facility designation bill naming several roads and an overpass for fallen officers, a military service member, and first responders. An amendment added the Sheriff Gary S. Borders Memorial Highway designation in Lake County. Members offered supportive remarks, and the bill passed 17-0. The committee then heard HB 703, which would require authorities such as FDOT or local governments to pay the costs when they require telecom providers to relocate infrastructure from public rights-of-way. Support came from Charter Communications, Associated Industries of Florida, and Florida Internet and Television, with discussion focused on the communication services tax and the cost burden of relocations. The bill passed unanimously 18-0. HB 1523 followed, addressing municipal utilities serving customers outside their boundaries by requiring public meetings, annual reporting, limits on transfers to general revenue, and reduced or eliminated surcharges for outside-boundary customers. Municipal utility representatives opposed parts of the bill, citing rural impacts, debt obligations, and the need for a glide path, while supporters argued for transparency and fairness to ratepayers outside municipal boundaries. An amendment changed a reporting date to January 31, 2026, and the bill passed 14-4. HB 867 established a legal framework for commuter rail operations along Florida’s coastal corridor, including insurance and indemnification arrangements for Miami-Dade, Broward, and Palm Beach counties using the Florida East Coast Railway right-of-way. An amendment clarified that Florida East Coast Railway and Brightline are not state entities and do not have sovereign immunity unless expressly provided by law. The bill passed 18-0. Finally, HB 1137 clarified a prior energy preemption law by adding boards, agencies, commissions, and authorities of counties and municipal corporations to the entities covered, aimed at preventing discriminatory energy-source practices by an appointed board. Public testimony included support from the Florida Natural Gas Association and the Florida Home Builders Association and opposition from Florida Student Power. Members noted the bill was a cleanup measure, and it passed favorably.

Transcript Highlights:

• So it might be cheaper to use a different drug without this.
• Twenty-four cents out of every dollar is drugs.
• These are specialty drugs.
• They're drugs that are thousands of dollars a month. That's uncontest. expensive drugs.
• These are specialty drugs. ...cholesterol pill.

Committee: House Health and Welfare

Transcript Highlights:

• It's not just the actual drug itself.
• So you probably have these numbers, colleagues, because drugs have certain end users.
• And unfortunately, in this country, we've treated drugs a certain way.
• , and all in all, over $300 million in drug money has been seized.
• Every identification helps remove drugs and their dealers from the community.

Committee: Senate Appropriations Committee on Criminal and Civil Justice

Summary: The Appropriations Committee on Criminal and Civil Justice met to continue its review of performance measurement in the criminal justice system. The first presentation, from State Courts Administrator Eric McClure, described how the court system uses multiple data sources to track filings, dispositions, clearance rates, workload, and support services, and how those data inform judge need, budget requests, resource allocation, and court administration. He also discussed ongoing efforts to improve case-level reporting, the use of case management systems in trial and appellate courts, and performance efforts in problem-solving courts and civil case management. McClure noted that the legislature provides dedicated funding for problem-solving courts and for medication-assisted treatment, and that the courts are required to report outcomes and monitor compliance with contract requirements. Melanie Brown-Whor of the Florida Behavioral Health Association then reviewed the medication-assisted treatment program funded through the courts budget. She said the program combines medication with counseling and behavioral supports, serves people involved in or at risk of criminal justice involvement, and has expanded over time to include additional medications and more counties. She reported improved engagement and retention, with more than 10,000 people screened over five years, about 9,200 receiving medication, and over 6,600 successfully discharged. Senators asked about racial and ethnic demographics, hospital referrals, and how services are delivered; Brown-Whor explained that local community providers deliver treatment under contract and that the program is working to improve data reporting and consistency. The Department of Law Enforcement then presented on investigations, forensics, and criminal justice information services. Deputy Commissioner Vaden Pollard outlined FDLE’s strategic plan and major investigative priorities, including cybercrime, targeted violence, crimes against children, mutual aid, and the SAFE fentanyl eradication program. He said SAFE has led to major seizures, arrests, and a reported decline in fentanyl deaths. Director Jason Bundy described FDLE’s forensic laboratory operations, DNA and rapid DNA capabilities, cold case and missing persons work, and the staffing and turnaround-time challenges tied to complex evidence testing. Director Lucy Saunders reviewed FDLE’s criminal history, biometric, incident-based crime reporting, and criminal justice transparency systems, noting that Florida is still transitioning agencies from summary reporting to incident-based reporting. The committee raised questions about Rapid DNA deployment, cold case coordination, and the slow pace of NIBRS/FIBRS adoption. No votes were taken, and the meeting adjourned after the presentations and questions.

Transcript Highlights:

• I am a little bit worried about how it is worded with influencers.
• Any product placement, promotion, and influence, or change for compensation in other manners, such as

Bills: HB220 , HB783 , HB2240 , HB3336 , HB4202 , HB4449 , HB4904 , HB3441 , HB4284

Committee: Senate State Affairs

Transcript Highlights:

• long-term, or other competing drugs' availability.
• So we shouldn't do an end run around these processes for individual drugs.
• Access Drug List without any step therapy or prior authorization.
• I think we've kind of talked about this specific drug, and the testimony was talking about drugs coming
• So I've heard today that this drug, Jernivix, costs $360 for 14 days.

Committee: Senate Senate Health and Human Services COR

Summary: The committee first approved the March 11 minutes and heard a presentation from Nathan Smith, CEO of Central Arizona Shelter Services, on homelessness in Maricopa County. He described rising homelessness, especially among older adults, and said CASS uses low-barrier emergency shelter, family shelter, and an older-adult shelter with case management, behavioral health services, and partnerships with outside groups for food, banking, digital access, and other supports. Members asked about collaborations with mutual aid groups and about point-in-time data, and Smith said the county data could be drilled down through AZMAG. The committee then moved to legislation. HB 2248, the Arizona Medical Freedom Act, would bar businesses, schools, and government entities from denying services or employment based on medical interventions, with an amendment allowing schools to limit access during outbreaks or for certain infections. Supporters framed the bill as protecting bodily autonomy and informed consent, while opponents argued it would undermine employers’ ability to prevent disease spread. The committee adopted the amendment and gave the bill a due pass recommendation on a 4-3 vote. HB 2906, requiring one dental board member to be an active oral and maxillofacial surgeon, passed unanimously after testimony that the board needs surgical expertise for complex cases and anesthesia oversight. HB 2189, directing the Nursing Board to adopt rules for licensed health aides and routine ventilator care, also passed with an amendment and a 6-0 vote. HB 2403 appropriates $2.5 million in FY2027 for home and community-based services providers for elderly and physically disabled Arizonans. Supporters said the funding would help retain caregivers, whose wages have lagged for years, and argued home care is cheaper than hospitalization or institutional care; the bill passed 6-0. HB 2731 continued the Physician Assistant Board to 2030 and passed with a technical amendment, and HB 2730 continued the Occupational Therapy Board and passed as well. HB 2729 continued the Nursing Board to 2030; the board said it regulates about 150,000 licensees and handles thousands of complaints annually, and the bill passed 6-0. HB 2728 continued the Department of Economic Security and incorporated several previously vetoed policy provisions affecting SNAP, unemployment, and eligibility/redetermination rules. Speakers in opposition said it would make benefits harder to access and turn a continuation bill into a vehicle for controversial policy changes, while supporters argued it was part of the legislature’s oversight role. The bill passed 4-3. The committee also adopted a strike-everything amendment to HB 2048, which limits utilization controls on FDA-approved non-opioid pain medications relative to opioids; supporters said it would improve access to non-opioid pain treatment and reduce opioid harm, while opponents warned it would bypass clinical review and raise costs. HB 2048 passed 4-3. Finally, HCR 2058 would require a comprehensive claim-level audit of Arizona Medicaid claims and direct recovery efforts for misappropriated funds; supporters said it could recover significant overpayments, while opponents questioned its incentives and overlap with existing oversight. The resolution passed 4-3, and the committee adjourned.

Transcript Highlights:

• Our United States Drug Enforcement Administration tried classifying kratom as a Schedule 1 drug back
• Our United States Drug Enforcement Administration tried classifying Kratum as a Schedule 1 drug back
• You can take a lot of drugs to help with pain. You can take a lot of drugs to help with sleep.
• You can take a lot of drugs to help with pain. You can take a lot of drugs to help with sleep.
• That's a drug habit. That's not a caffeine habit. That's a drug habit.

Summary: The Kratom Working Group met to hear public testimony and expert presentations on whether North Dakota should prohibit or regulate kratom and 7-OH products. Early testimony split sharply between speakers who described natural kratom as a helpful, lower-risk alternative for chronic pain, opioid withdrawal, PTSD, and recovery, and speakers who urged prohibition because of dependence, overdose risk, and the growth of concentrated or synthetic 7-OH products sold in gas stations, smoke shops, and online. Several witnesses, including consumers and shop owners, argued that banning kratom would push people to more dangerous drugs or unregulated internet sources, while public health and medical witnesses said the marketplace is confusing and inadequately controlled. A number of witnesses, including representatives of the North Dakota Public Health Association, the state crime lab, and addiction-treatment and pediatric clinicians, emphasized risks from adulterated or concentrated products, lack of labeling and age restrictions, contamination concerns, and harms to adolescents, pregnant patients, and newborns. The crime lab described recent cases involving mitragynine, 7-OH, and pseudoindoxyl, and said products purchased in a smoke shop were inaccurately labeled. A Sanford pediatric hospitalist testified that kratom exposure in pregnancy can cause severe neonatal withdrawal and that adolescents are using the product. By contrast, American Kratom Association representatives and other advocates argued that natural leaf kratom should be distinguished from synthetic 7-OH, that deaths usually involve other substances, and that a regulatory framework with testing, labeling, age limits, and product registration would better protect consumers than a blanket ban. No formal bill was debated or voted on in this transcript. The working group heard testimony, asked questions, and took no final action before breaking for lunch and later resuming with additional presentations.

Transcript Highlights:

• The first is the Florida drug Court case management system.
• And then you can see underneath their drug court DUI march when acts and that sort of thing.
• So you probably have these numbers, colleagues because drugs have certain in uses.
• And unfortunately in this country we've treated drug for a certain way based on again, you, sir.
• and all in all over 300 million and drug money has been seized.

Transcript Highlights:

• Drug and Pharmacy Benefit Managers Compliance.
• Implementation of the Prescription Drug Transparency Act.
• They are also protected from reporting rebate information for any specific drug product or drug class
• Drug clinics, that kind of thing.
• the top 25 drugs with the highest increase in total spending.

Committee: House Legislative Health & Human Services Committee

Transcript Highlights:

• These prisoners were serving mandatory minimum sentences for drug offenses.
• As you know, President Trump recently changed the classification of marijuana from a drug...
• I would say the quality of the drug as it's available in legal stores in Maine is suspect.
• I believe we haven't lived in a culture that allowed the drug and its use to be studied.
• As the drug has been legalized, we've seen usage... ...standard usage as the drug has been legalized

Summary: The Special Joint Committee on Initiative Petitions held a public hearing on Initiative Petition 25-10, House Bill 5002, titled “An Act to Restore a Sensible Marijuana Policy,” which would repeal Massachusetts’ adult-use cannabis legalization framework. Chairs Brendan Crighton and Kate Hogan outlined the Article 48 initiative process and explained that the committee is gathering testimony for a report to the legislature. The hearing was organized into expert, proponent, opponent, and public testimony, with written testimony accepted through March 27. The first witness, Jessica Trow of MassBudget, testified in opposition to repeal and focused on cannabis-related revenue and social equity. She said legalization has generated nearly $2 billion statewide since adult-use sales began, with revenue flowing through the Marijuana Regulation Fund, the state sales tax, and local taxes and fees. She emphasized that funds support public health, the Cannabis Control Commission’s social equity work, the Cannabis Social Equity Fund, and municipal budgets, and argued that legalization has created pathways for communities harmed by prohibition. The petition’s spokesperson, Wendy Wakeman, argued in favor of repeal, saying legalization has worsened public health, safety, and quality of life, citing higher potency, addiction, youth use, impaired driving, workplace positives, and black-market concerns. Committee members questioned her about the data sources, the will of the voters, the role of paid signature gatherers, and the petition’s funding, including out-of-state and dark-money concerns. Opponents of the initiative then testified that repeal would harm a regulated industry that has created jobs, tax revenue, and social equity opportunities. Caroline Pino of STEM, Kristen Rogers of Levia, Judith Ledbetter of Project De-Stigmatized Healthcare, and Armani White of Firehouse Dispensary/EON described their businesses, community investments, and personal reliance on cannabis, and warned that repeal would push consumers back to the illicit market and undermine equity programs. In public testimony, Lucas Thayer of the Massachusetts Cannabis Reform Coalition and Jeff Rawson, a chemist and consumer protection advocate, also opposed the measure, arguing that regulated cannabis is safer than unregulated products and that repeal would damage investments and public safety. The hearing ended after the public testimony, and the committee voted to close the hearing.

Transcript Highlights:

• As background, biological products are regulated by the federal Food and Drug Administration.
• products are manufactured, they cannot be replicated in the same way as traditional chemical-based drugs
• Under state and federal law, a pharmacist may substitute a brand-name drug or biological product with
• Instead, it authorizes a pharmacist to substitute a therapeutically equivalent drug or interchangeable
• And if all the biosimilars are preferred drugs, it should yield a lower cost sharing.

Committee: House Health Care & Wellness

Transcript Highlights:

• In Arizona, if a new drug is approved by the Food and Drug Administration, a lot of states have that
• drug go into effect automatically.
• In Arizona, we have to name each drug before it goes.
• I'm not saying this is a miracle drug.
• The Food and Drug Administration, as was previously mentioned, has not yet approved this drug, and as

Bills: SB1161 , SB1215 , SB1270 , SB1400 , SB1537 , SB1538 , SB1580 , SB1584 , SB1627

Committees: House Public Safety & Law Enforcement , House House Public Safety & Law Enforcement Committee of Reference

Keywords: appropriation, public safety, Yuma County, funding exemption, family advocacy center, firefighters, occupational disease, workers compensation, cancer presumption, police officers, hazardous duty, SB1270, Arizona retirement system, public safety personnel, defined contribution plan, correctional officers, corrections officers, retirement contributions, supplemental contributions, retention incentive

Transcript Highlights:

• ... ...to law enforcement agencies to arrest, prosecute, and incarcerate people on illegal drug-related
• These policies are known as the war on drugs, and they resulted in mass incarceration disproportionately
• the state's prisoners, and 75% of these people were serving mandatory minimum sentences... ...for drug
• As you know, President Trump recently changed the classification of marijuana from a drug...
• I would say the quality of the drug as it's available in legal stores in Maine is suspect.

Bills: H5005

Committee: Joint Special Joint Committee on Initiative Petitions

Keywords: environment, water conservation, natural resources, public funding, environmental justice

Summary: The Special Joint Committee on Initiative Petitions held a hearing on Initiative Petition 25-10 / House Bill 5002, “An act to restore a sensible marijuana policy,” which would repeal Massachusetts’ adult-use cannabis legalization framework. The chair explained the Article 48 initiative process and noted that, if the Legislature does not enact the measure as written, additional signatures would be needed for it to qualify for the 2026 ballot. The committee heard testimony from an expert, proponents of the petition, opponents, and members of the public, and accepted written testimony through March 27 at 5 p.m. Jessica Trow of MassBudget testified first, focusing on cannabis revenue and spending in Massachusetts. She said legalization has generated nearly $2 billion for the Commonwealth and municipalities since FY 2018, including excise tax, sales tax, local option taxes, fees, and community impact fees. She described how revenues are distributed to public health, the Cannabis Control Commission’s social equity efforts, the cannabis social equity fund, the MBTA, the School Building Authority, the general fund, and local budgets, and argued the industry has supported social equity and community investments. Opponents of the petition argued that repeal would harm public health, consumer safety, jobs, tax revenue, and social equity programs. Wendy Wakeman, speaking for the ballot committee, said legalization has increased potency, addiction, and mental health concerns, and that the state lacks sufficient data on harms. In contrast, business owners, clinicians, and advocates including Caroline Pino, Kristen Rogers, Drudus Ledbetter, Armani White, Lucas Thayer, and Jeff Rawson said the regulated market provides tested products, jobs, tax revenue, and pathways for people harmed by prohibition, while repeal would push consumers back to the illicit market and undermine equity goals. Committee members questioned witnesses about the evidence base, the role of out-of-state funding, the petition’s impact on existing businesses, and whether narrower regulatory fixes might address concerns instead of repeal. No vote was taken; the hearing was closed after testimony ended.

Transcript Highlights:

• Consider the data between Access to FDA-approved drugs that are safe and effective.
• Drug companies often keep these drug prices high by setting their own list prices and then offering co-pay
• Companies also use drug coupons to increase drug sales for a particular brand-name drug and to steer
• It's directly between the patient and the pharmacy and the drug company.
• She noted that the affordability of drug costs is important to everyone.

Committee: Senate Health

Summary: The committee heard several health-related bills, beginning with SB 1124 on lung cancer screening awareness. The author and supporters said the bill would require CDPH signage about lung cancer screening eligibility at tobacco point-of-sale locations to address low awareness and low screening rates. Support came from medical students, physicians, and the California Academy of Family Physicians, while retailers raised concerns about sign size, retailer notification, and implementation. Committee members generally supported the bill and noted the need to work through those concerns. SB 1150 sought to require clearer patient notice when cancer cases are reported to the California Cancer Registry. The author described the bill as a response to inconsistent notification practices and privacy concerns, and the chair and other members shared personal stories about learning they or family members were in the registry without knowing it. Cancer registry and university stakeholders expressed appreciation for amendments but continued to have concerns or wanted more time to review the language. The bill was discussed as a patient-awareness measure rather than a change to reporting requirements. The committee also heard SB 1400 on Alameda Health System governance, SB 1094 on biosimilar substitution and health plan policies, SB 1314 on smoke shop regulation and nitrous oxide restrictions, and SB 1309 on eliminating cost-sharing for medically necessary follow-up after lung cancer screening. SB 1400 and SB 1314 drew support from local officials, labor, and public health advocates, with members emphasizing youth protection and local oversight. SB 1094 passed after extensive debate over pharmacist substitution authority and notification requirements, with a 6-0 vote and opposition from biotechnology and physician groups. SB 1309 also passed after members discussed the cost of follow-up care and the value of early detection, despite opposition from health plans over premium impacts; it received a 7-0 vote and was placed on call.

Transcript Highlights:

• um illicit drug use and and<00:43:02.240><c> drug</c><00:43:02.640><c> possession</c><00:43:03.640><
• And just a final comment: you call it a war on drugs.
• ><c> court</c> see um somebody from the drug court see um somebody from the drug court that's<00:46:22.160
• </c> represent no um I don't know about drug represent no um I don't know about drug I<00:46:42.240><
• ><c> particular</c> I mean drug court in particular I mean drug court in particular potentially<00:46

Committee: House Public Safety Finance and Policy

Transcript Highlights:

• Yeah, and I think one of the issues with some drug checking equipment is that it doesn't tell you how
• I think Brandeis—we can look; Brandeis does materials related to their drug checking activities, does
• And I hear you as far as bolstering our drug checking could improve them.
• Any additional comments, feedback before we go into people who use drugs and people in recovery?
• I just had a question about the role of the Attorney General in this kind of emerging drug issue.

Summary: The Special Commission on the Public Health Effects of Xylazine held its fifth and final public meeting to review and approve the final draft of its report before submission to the House and Senate clerks. Chair Mindy Domb opened the meeting, noted Senator John Keenan’s absence due to National Guard deployment, approved the prior meeting minutes, and explained the process for incorporating final edits and late votes into appendices. Commissioners then voted to allow staff to make agreed-upon language changes after the meeting, and later voted on the final report itself. Staff walked commissioners through the report’s redlines and substantive updates. Changes included clarifying that xylazine is an active adulterant rather than simply a bulking agent, replacing “non-clinician” with “non-clinical staff,” removing or revising references to “hotspots” in favor of more accurate language about local trends, and refining language on wound care to refer to medical consequences and financial costs. The report also added or strengthened discussion of harm reduction measures such as drug checking, mobile health services, overdose prevention centers, oxygenation and airway support during overdose response, and the importance of naloxone remaining available while recognizing its limits for xylazine exposure. Commissioners also discussed data collection, legal protections for drug checking, and the role of the Attorney General in guidance and coordination on emerging drug threats. The commission then took a final vote, with the members present voting to approve the report. A letter from Senator Velis, who was also absent due to active duty orders, was read into the record expressing support for the report and its recommendations. In closing comments, commissioners and staff thanked one another for the collaborative work and described the report as a useful public health resource. Chair Domb adjourned the meeting at 11:11 a.m., noting that the final report would be submitted and posted online for public access.

Transcript Highlights:

• </c><00:17:57.200><c> uh</c><00:17:57.360><c> in</c> Drug Policy Forum of Havaii. uh in Drug Policy Forum
• Nicholas Leens Drug Policy Forum of AI in<00:41:50.800><c> support.
• </c> members, uh Nikos Levers with Drug members, uh Nikos Levers with Drug Policy<00:41:57.200><c> Forum
• </c> schedule three drug right? schedule three drug right?
• 43.840><c> and</c><01:15:44.159><c> medical</c> non-prescription drugs and medical non-prescription drugs

Summary: The committee heard testimony on SB 3025, relating to medical debt, with multiple organizations and individuals, including the Office of Wellness and Resilience, Healthcare Association of Hawaii, Queens Health Systems, the American Cancer Society Cancer Action Network, Aloha Care, Hawaii Health and Harm Reduction, Hawaii Data Collaborative, and Hawaii Appleseed, all speaking in support. No opposition was heard, and the member present had no questions. The committee then took up SB 3199, which would establish a mental health emerging therapies task force. Testimony was overwhelmingly in support, with speakers including veterans, clinicians, researchers, and advocacy groups describing personal experiences with PTSD, depression, traumatic brain injury, and treatment-resistant conditions, and arguing that Hawaii should prepare for regulated access to emerging therapies such as MDMA, psilocybin, ketamine, and ibogaine. The Department of Health and some medical organizations provided comments, and one opposition witness was called but not present. The chair noted broad support, especially from veterans, and no vote was taken during the excerpt. The final measure discussed was SB 3324, relating to Medicaid. The Department of Human Services, Department of Health, Hawaii State Council on Developmental Disabilities, Hawaii Disability Rights Center, Aloha Care, and numerous care-provider and aging/disability organizations testified in support, while one witness was in opposition and several others offered comments. The discussion then moved to SB 2563, relating to homelessness, where the Department of the Attorney General offered comments on specific sections and recommended adopting suggested amendments if the bill proceeds. Additional testimony on SB 2563 began with support from several individuals, including Shelby Pikachu, who emphasized the severity of homelessness and related social problems in the community.

Transcript Highlights:

• On September 11, 2025, I got clean from drugs.
• Now, I'd never done a drug up to that point. I'd never smoked marijuana.
• The drug list without any step therapy or prior authorization.
• I think we've kind of talked about this specific drug and the testimony was talking about drugs coming
• So I've heard today that this drug, Jernivix, costs $360 for 14 days.

Bills: HB2048 , HB2189 , HB2248 , HB2403 , HB2728 , HB2729 , HB2730 , HB2731 , HB2906 , HCR2058

Committees: Senate Health and Human Services , Senate Senate Health and Human Services COR

Keywords: orders of protection, domestic violence, court procedures, legal guardian, enforcement, healthcare, licensed health aides, scope of practice, ventilator care, training standards, medical freedom, healthcare mandates, employment requirements, public health, government regulation, elderly, physical disabilities, Arizona Health Care Cost Containment System, home and community based services, funding increase

Transcript Highlights:

• first up, GM544 submitting for consideration, um, Emily Andrade for the Hawaii Advisor Commission on Drug
• I'm the administrator of the alcohol and drug abuse division.
• So next up, GM545, Lilinoi Kavha Kawa Kawa Hikawa, um, for again drug abuse and controlled substances
• I'm the administrator of the alcohol and drug abuse division.
• </c> Drug Abuse and Controlled Substances. Drug Abuse and Controlled Substances.

Committee: Senate Health and Human Services

Summary: The Health and Human Services Committee heard and considered a series of gubernatorial nominations and reappointments, primarily to the Hawaii Advisory Commission on Drug Abuse and Controlled Substances, the State Council on Developmental Disabilities, the Hawaii Health Systems Corporation board, the Commission on Fatherhood, and the Policy Advisory Board for Elder Affairs. Testimony was overwhelmingly supportive across the measures. The Department of Health repeatedly testified in support of the drug and controlled substances nominees, and several nominees and supporters emphasized experience in public health, rural health access, disability advocacy, family services, and elder affairs. Some nominees were not present live but had submitted written answers, which the chair noted had been posted online. For the developmental disabilities nominations, testimony highlighted lived experience and representation from neighbor islands, with supporters saying the nominees would bring valuable perspectives and help strengthen services and advocacy. For the Hawaii Health Systems Corporation nominations, testimony stressed rural health, system collaboration, and broad community and hospital experience. The Commission on Fatherhood nominee said he wanted to advocate for fathers and be a voice for them, and supporters from Maui Family Support Services backed that nomination. The elder affairs nominee also received support from caregiver and aging-related organizations. At the end of the hearing, the committee moved to advise and consent on the nominations it had heard, and each recommendation was adopted by the members present. The chair noted that all members were present for the votes, and the meeting concluded with congratulations to the nominees and adjournment.